4Stokkel MP, Linthorst MF, Borm JJ, et al. A reassessment of bonescintigraphy and commonly tested pretreatment biochemical parametersin newly diagnosed osteosarcoma[J]. J Cancer Res Clin Oncol,2002,128(7) :393 - 399. 被引量：1
二级参考文献5
1Levine E, Lee KR, Neff JR, et al. Comparison of computed tomography and other image modalities in the evaluation of musculoskeletal tumors[J]. Radiology, 2003, 131:431-437. 被引量：1
3Bajpai J, Sharma M, Sreenivas V, et al. VEGF expression as a prognostic marker in osteosarnoma[J]. Pediatr Blood Cancer, 2009,53(6) :1035-1039. 被引量：1
4Wang E, Foo WC, Huang Q. A sinusoidal large cell lymphoma with expression of CD30, CD15, and multiple B-cell antigens: a classical Hodgkin lymphoma with sinusoidal infiltrating pattern or a sinusoidal CD30 positive large B-cell lymphoma with CD15?[J]. LeukLymphoma,2010,51(6):1148-1151. 被引量：1
5Konety B R. Molecular marks in bladder cancer: a critical appraisal [J]. Vrol Oncol,2006,24(4):326-329. 被引量：1
6Ymera P, Giovanni G, Giuliana C, et al. Sorafenib blocks tumour growth, angiogenesis and metastatic and potential in preclinical mod- els of osteosarcoma through a mechanism potentially involving the in hibition of ERK1/2, MCL1 and ezrin pathways [J]. Molecular Cancer, 2009,8 (118) : 1476-1483. 被引量：1
7Barbara R,Giovanni S, Giulio M, et al. Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical a nalysis[J]. BMC Musculoskeletal Disorders, 2010,11 ( 34 ) : 1471-1474. 被引量：1
